Depomed Announces Corporate Governance Updates
May 22, 2017 11:32 am UTC| Business
NEWARK, Calif., May 22, 2017 -- Depomed, Inc. (Nasdaq:DEPO) today announced that following a comprehensive review of the Company's corporate governance practices, the Board of Directors has taken a number of actions...
Depomed Announces Corporate Governance Updates
May 22, 2017 11:33 am UTC| Business
NEWARK, Calif., May 22, 2017 -- Depomed, Inc. (Nasdaq:DEPO) today announced that following a comprehensive review of the Company's corporate governance practices, the Board of Directors has taken a number of actions...
May 22, 2017 11:32 am UTC| Business
MENLO PARK, Calif., May 22, 2017 -- A series of recent peer-reviewed scientific publications highlights the growing use of Single Molecule, Real-Time (SMRT®) Sequencing to annotate plant and animal genomes. These...
May 22, 2017 11:32 am UTC| Business
MENLO PARK, Calif., May 22, 2017 -- A series of recent peer-reviewed scientific publications highlights the growing use of Single Molecule, Real-Time (SMRT®) Sequencing to annotate plant and animal genomes. These...
May 22, 2017 11:32 am UTC| Business
MENLO PARK, Calif., May 22, 2017 -- A series of recent peer-reviewed scientific publications highlights the growing use of Single Molecule, Real-Time (SMRT®) Sequencing to annotate plant and animal genomes. These...
May 22, 2017 11:31 am UTC| Business
WALTHAM, Mass., May 22, 2017 -- EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) (“EyeGate” or the “Company”), a specialty pharmaceutical company that focuses on developing and commercializing products for treating diseases...
May 22, 2017 11:31 am UTC| Business
WALTHAM, Mass., May 22, 2017 -- EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) (“EyeGate” or the “Company”), a specialty pharmaceutical company that focuses on developing and commercializing products for treating diseases...